Pancreatic Cancer Research

ResearcherBaylor College of MedicineActive in the last 2 years

Ru Chen

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0002-1823-0686; OpenAlex author ID A5100724602; NIH RePORTER profile ID 7284983. Sources: funder_awards.

Their work

Papers
22 (first author 6, last author 7)
Trials
0
Grants
6
Labs led
2
Collaborators
36
Papers, trials and grants by year

2006: 1 grant · 2007: none · 2008: none · 2009: none · 2010: none · 2011: 1 paper, 1 grant · 2012: 2 papers, 1 grant · 2013: 3 papers · 2014: 1 paper · 2015: 3 papers · 2016: 1 paper · 2017: 2 papers · 2018: 1 grant · 2019: 1 paper · 2020: 3 papers · 2021: 1 paper · 2022: 2 papers · 2023: 1 paper · 2024: 1 grant · 2025: none · 2026: 1 paper, 1 grant

Papers 22

  1. Development of a multiplex assay for early detection of pancreatic cancer in high-risk groups. Last author DOI 10.1186/s12885-026-16058-3↗
  2. Protein Advanced Glycation End Products and Their Implications in Pancreatic Cancer. Last author DOI 10.1158/1940-6207.capr-23-0162↗
  3. Increased neutrophil infiltration as a body-wide effect in pancreatic cancer development. Co-author DOI 10.1016/j.ebiom.2022.104089↗
  4. Proteomes of Extracellular Vesicles From Pancreatic Cancer Cells and Cancer-Associated Fibroblasts. Co-author DOI 10.1097/mpa.0000000000002115↗
  5. X-aptamers targeting Thy-1 membrane glycoprotein in pancreatic ductal adenocarcinoma. Co-author DOI 10.1016/j.biochi.2020.11.018↗
  6. Proteome alterations in pancreatic ductal adenocarcinoma. Last author DOI 10.1016/j.canlet.2019.11.020↗
  7. Promoter-Level Transcriptome Identifies Stemness Associated With Relatively High Proliferation in Pancreatic Cancer Cells. Co-author DOI 10.3389/fonc.2020.00316↗
  8. Systemic Proteome Alterations Linked to Early Stage Pancreatic Cancer in Diabetic Patients. Last author DOI 10.3390/cancers12061534↗
  9. Predictive proteomic signatures for response of pancreatic cancer patients receiving chemotherapy. First author DOI 10.1186/s12014-019-9251-3↗
  10. Spectral library-based glycopeptide analysis-detection of circulating galectin-3 binding protein in pancreatic cancer. First author DOI 10.1002/prca.201700064↗
  11. Disrupting glutamine metabolic pathways to sensitize gemcitabine-resistant pancreatic cancer. Co-author DOI 10.1038/s41598-017-08436-6↗
  12. Glycoproteins and glycoproteomics in pancreatic cancer. Last author DOI 10.3748/wjg.v22.i42.9288↗
  13. Proteomics analysis of bodily fluids in pancreatic cancer. Last author DOI 10.1002/pmic.201400476↗
  14. Proteins associated with pancreatic cancer survival in patients with resectable pancreatic ductal adenocarcinoma. Co-author DOI 10.1038/labinvest.2014.128↗
  15. Combining in Vitro Diagnostics with in Vivo Imaging for Earlier Detection of Pancreatic Ductal Adenocarcinoma: Challenges and Solutions. First author DOI 10.1148/radiol.2015141020↗
  16. Quantitative glycoproteomics analysis reveals changes in N-glycosylation level associated with pancreatic ductal adenocarcinoma. First author DOI 10.1021/pr4010184↗
  17. Tissue proteomics in pancreatic cancer study: discovery, emerging technologies, and challenges. Last author DOI 10.1002/pmic.201200319↗
  18. Detection of pancreatic ductal adenocarcinoma in mice by ultrasound imaging of thymocyte differentiation antigen 1. Co-author DOI 10.1053/j.gastro.2013.06.011↗
  19. Unexpected gain of function for the scaffolding protein plectin due to mislocalization in pancreatic cancer. Co-author DOI 10.1073/pnas.1309720110↗
  20. Multiplex targeted proteomic assay for biomarker detection in plasma: a pancreatic cancer biomarker case study. First author DOI 10.1021/pr201117w↗
  21. Stromal galectin-1 expression is associated with long-term survival in resectable pancreatic ductal adenocarcinoma. Co-author DOI 10.4161/cbt.20842↗
  22. Protein alterations associated with pancreatic cancer and chronic pancreatitis found in human plasma using global quantitative proteomics profiling. First author DOI 10.1021/pr101148r↗

Grants 6

  1. BLOOD-BASED PROTEOMIC ASSAY FOR PANCREATIC CANCER DETECTION UH3CA292130↗
  2. BLOOD-BASED PROTEOMIC ASSAY FOR PANCREATIC CANCER DETECTION UH2CA292130↗
  3. Early detection of pancreatic cancer in diabetics R01CA180949↗
  4. Pancreatic Juice Biomarker for Pancreatic Cancer R21CA161575↗
  5. Protein biomarkers for detection of pancreatic cancer K07CA116296↗
  6. Protein Biomarkers for Detection of Pancreatic Cancer AWARD pancan:2006-ru-chen-phd-protein-biomarkers-for-detection-of-panc

Closest collaborators

The 25 strongest of 36 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Sheng Pan · 17 shared papers, 3 shared grants, 2011–2026 · strength 4.29
  2. Teresa A. Brentnall · 19 shared papers, 2011–2026 · strength 1.74
  3. Randall E. Brand · 4 shared papers, 2012–2026 · strength 0.55
  4. David W. Dawson · 3 shared papers, 2015–2022 · strength 0.35
  5. Sheng Pan · 1 shared paper, 2026 · strength 0.33
  6. Lakmini Kumari Senavirathna · 1 shared paper, 2023 · strength 0.31
  7. Yuanqing Yan · 2 shared papers, 2020–2022 · strength 0.27
  8. Kimberly A. Kelly · 3 shared papers, 2013–2021 · strength 0.23
  9. Diane M. Simeone · 2 shared papers, 2015–2022 · strength 0.21
  10. Sharon Pan · 1 shared paper, 2022 · strength 0.16
  11. Tatjana Crnogorac‐Jurcevic · 1 shared paper, 2022 · strength 0.16
  12. Hongyu Wang · 1 shared paper, 2021 · strength 0.14
  13. Jürgen K. Willmann · 3 shared papers, 2012–2015 · strength 0.13
  14. Hiroshi Seno · 1 shared paper, 2020 · strength 0.12
  15. Shigeo Takaishi · 1 shared paper, 2020 · strength 0.12
  16. Akihisa Fukuda · 1 shared paper, 2020 · strength 0.12
  17. Hong Peng · 1 shared paper, 2019 · strength 0.11
  18. Vincent J. Picozzi · 1 shared paper, 2019 · strength 0.11
  19. Hong Peng · 1 shared paper, 2020 · strength 0.11
  20. Suresh T. Chari · 1 shared paper, 2020 · strength 0.11
  21. Gloria M. Petersen · 1 shared paper, 2020 · strength 0.11
  22. Eslam Nouri-Nigjeh · 1 shared paper, 2017 · strength 0.08
  23. Roeland F. de Wilde · 2 shared papers, 2012–2015 · strength 0.07
  24. Niki A. Ottenhof · 2 shared papers, 2012–2015 · strength 0.07
  25. Anirban Maitra · 2 shared papers, 2012–2015 · strength 0.07

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.